[1] Dhawan D, Sharma S.Abdominal obesity, adipokines and non-communicable diseases[J]. J Steroid Biochem Mol Biol, 2020, 203: 105737. [2] Khanna D, Peltzer C, Kahar P, et al.Body mass index (BMI): A screening tool analysis[J]. Cureus, 2022, 14(2): e22119. [3] 中国营养学会肥胖防控分会, 西安交通大学全球健康研究院, 国际肥胖与代谢性疾病研究中心, 等. 2025年世界肥胖报告[J]. 西安交通大学学报(医学版), 2025, 46(2): 363-379. [4] 张晓帆, 王惠君, 苏畅, 等. 2000—2023年中国十省(自治区)成年居民超重肥胖及中心性肥胖的流行现况及趋势[J]. 卫生研究, 2024, 53(6): 874-879. [5] Tian X, Wang H.Projecting national-level prevalence of general obesity and abdominal obesity among Chinese adults with aging effects[J]. Front Endocrinol(Lausanne), 2022, 13: 849392. [6] Wu Y, Li D, Vermund SH.Advantages and limitations of the body mass index(BMI) to assess adult obesity[J]. Int J Environ Res Public Health, 2024, 21(6): 757. [7] 中国疾病预防控制中心慢性非传染性疾病预防控制中心. 中国慢性病及危险因素监测数据分析手册[M]. 北京: 人民卫生出版社, 2022: 50-58. [8] 彭绩, 余卫业. 深圳市慢性非传染性疾病流行病学调查研究(2018)[M]. 北京: 科学出版社, 2021: 129-140. [9] 深圳市大鹏新区疾病预防控制中心. 深圳市大鹏新区居民慢性病防控社会因素调查报告[EB/OL]. (2023-04-25)[2025-12-26]. http://www.dpxq.gov.cn/ztzl/mszt/yljs/tzgg/content/post_10560344.html. [10] 姚春阳, 谢亮, 高慧, 等. 嘉兴市成人超重肥胖现况调查[J]. 预防医学, 2025, 37(11): 1108-1112. [11] Liu M, Jia C, Hu Y, et al.Prevalence and factors associated with overweight, obesity and central obesity among adults in Shenmu City, Shaanxi Province, China[J]. Prev Med Rep, 2024, 40: 102673. [12] 杨洋, 何田静, 祝淑珍, 等. 成年人群睡眠与肥胖的关联研究[J]. 预防医学, 2023, 35(2): 116-120. [13] da Silva NC, Thomaz da Silva GPJ, Onofri SMM, et al. Obstructive sleep apnea and orofacial myofunctional aspects in obesity[J]. Sleep Breath, 2023, 27(4): 1351-1358. [14] Duksal F, Eren F. Evaluation of thyroid functions and obesity in obstructive sleep apnea syndrome[J]. Rev Assoc Med Bras(1992), 2023, 18; 69(9): e20230376. [15] Figorilli M, Velluzzi F, Redolfi S.Obesity and sleep disorders: A bidirectional relationship[J]. Nutr Metab Cardiovasc Dis, 2025, 35(6): 104014. [16] 刘熠华, 杨晓晨, 张晓悦, 等. 职业人群不同健康行为对肥胖患病风险的替代作用研究[J]. 中国预防医学杂志, 2025, 26(3): 373-377. [17] Ruze R, Liu T, Zou X, et al.Obesity and type 2 diabetes mellitus: Connections in epidemiology, pathogenesis, and treatments[J]. Front Endocrinol(Lausanne), 2023, 21(14): 1161521. [18] Jiang SZ, Lu W, Zong XF, et al.Obesity and hypertension[J]. Exp Ther Med, 2016, 12(4): 2395-2399. [19] Bays HE, Kirkpatrick CF, Maki KC, et al.Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the obesity medicine association and the national lipid association 2024[J]. J Clin Lipidol, 2024, 18(3): e320-e350. [20] Khanna D, Peltzer C, Kahar P, et al.Body mass index(BMI): A screening tool analysis[J]. Cureus, 2022, 14(2): e22119. |